Bortezomib: A New Pro-Apoptotic Agent in Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|1|55-67

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.1, 2010-02, pp. : 55-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Development of Pro-Apoptotic Cancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review

By Bizzarri Mariano   Proietti Sara   Cucina Alessandra   Reiter Russel J  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1483-1496

Informa Healthcare

Access to resources Recommend Favorite

A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells

By Singh Rakesh   Lange Thilo   Kim Kyu   Brard Laurent  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 63-72

Springer Publishing Company

Access to resources Recommend Favorite

Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines

By  

Current Cancer Drug Targets, Vol. 16, Iss. 4, 2016-04 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 11, Iss. 7, 2005-03 ,pp. : 933-944

Bentham Science Publishers

Access to resources Recommend Favorite